<DOC>
	<DOCNO>NCT02578784</DOCNO>
	<brief_summary>The incidence hemodynamically relevant dialysis fistula stenoses/obstructions 1 year 60-90 % ( 62.5 91 % radiocephalic , brachiocephalic 70-84 % , PTFE shunt 62-87 % ) , necessitate therapeutic measure preserve dialysis access period 1/3 patient . This therapeutic measure dilatation stenosis use standard PTA balloon ( POBA , plain old balloon angioplasty primary technical success rate 50-79 % [ 2-4 ] .In turn , 21-50 % case insufficient PTA result obtain ( so-called POBA-resistant stenosis ) . In case , predilatation so-called cutting balloon ( carry small knife surface ) perform , lead success rate 89 % . However , problem high incidence restenosis , 40 % recurrent stenosis 10 % de novo stenosis . The use drug-coated balloon ( DCB ) non-POBA resistant stenosis lead reduction restenosis rate 35 % 5 % . However , effect DCB POBA resistant stenosis unknown . Therefore , aim study evaluate clinical benefit combine use cut balloon drug-coated balloon POBA resistant dialysis fistula stenosis compare sole use cut balloon .</brief_summary>
	<brief_title>DEB-after-Cutting Balloon-PTA Dialysis Fistula Stenosis</brief_title>
	<detailed_description />
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>dialysis fistula dysfunction require cut balloon angioplasty miss informed consent unable consent age &lt; 18 year pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Dialysis</keyword>
</DOC>